Research and innovation news

Manchester research links two types of less-often prescribed diabetes drugs with lower chances of potentially fatal heart problems – in people with type 2 diabetes without established heart disease.

The NHS has struck a deal for a life-saving treatment that will offer babies and young children with a rare and life-limiting genetic disease the prospect of a normal life.

Researchers at Saint Mary’s Hospital will explore the effectiveness of an innovative new self-management programme for women with pelvic organ prolapse.

Researchers at The Christie and CRUK, supported by MFT's North West Genomics Laboratory Hub, are investigating a new blood test that could detect if melanoma patients are relapsing sooner.

A study led by Manchester University NHS Foundation Trust (MFT) and The University of Manchester researchers has revealed that obesity is likely to cause an increased risk of kidney disease.

Pioneering research at Saint Mary’s Hospital is trialling cannabidiol (CBD) – in conjunction with the NHS standard of care – as a potential treatment for newborns with moderate or severe brain injury.

Advances in technology and data from pacemakers are alerting Manchester doctors of heart failure patients who may benefit from medical attention.

A new trial opens in Greater Manchester today which is to test cutting-edge wearable technologies involving patients who have received cancer treatment.